Several studies of ACPA positive individuals who ultimately developed RA have shown that as RA onset approaches, the ACPA response exhibits epitope spreading with expansion of the targeted autoantigens and increasing levels of glycosylation in the variable region domains, both of which are associated with increases in the circulating levels of these autoantibodies (5, 18). This evidence concerns the gene PRTN3 and rheumatoid arthritis.